Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression

Immune checkpoint blockade (ICB) has revolutionized cancer therapy but has had limited utility in several solid tumors such as breast cancer, a major cause of cancer-related mortality in women. Therefore, there is considerable interest in alternate strategies to promote an anti-cancer immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamage, Hashni Epa Vidana, Shahoei, Sayyed Hamed, Albright, Samuel T., Wang, Yu, Smith, Amanda J., Farmer, Rachel, Fink, Emma C., Jacquin, Elise, Weisser, Erin, Bautista, Rafael O., Henn, Madeline A., Schane, Claire P., Nelczyk, Adam T., Ma, Liqian, Gupta, Anasuya Das, Bendre, Shruti V., Nguyen, Tiffany, Tiwari, Srishti, Krawczynska, Natalia, He, Sisi, Tjoanda, Evelyn, Chen, Hong, Sverdlov, Maria, Gann, Peter H., Boidot, Romain, Vegran, Frederique, Fanning, Sean W., Apetoh, Lionel, Hergenrother, Paul J., Nelson, Erik R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462080/
https://www.ncbi.nlm.nih.gov/pubmed/37645737
http://dx.doi.org/10.1101/2023.08.14.553229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462080/
https://www.ncbi.nlm.nih.gov/pubmed/37645737
http://dx.doi.org/10.1101/2023.08.14.553229

Ejemplares similares